Lv1
28 积分 2022-09-19 加入
BCMA-CAR T-cells in a patient with relapsing idiopathic inflammatory myositis after CD19-CAR T-cells
10小时前
待确认
Engineering innate immune cells for cancer immunotherapy
2天前
已完结
Advancements and challenges in CAR T cell therapy in autoimmune diseases
26天前
已完结
Development of a Me2SO-free cryopreservation medium and its long-term cryoprotection on the CAR-NK cells
1个月前
已完结
Preparation and characterization of a chimeric CD 19 monoclonal antibody
3个月前
已完结
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
4个月前
已完结
A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy
4个月前
已完结
Association of CD19+-targeted chimeric antigen receptor (CAR) T-cell therapy with hypogammaglobulinemia, infection, and mortality
4个月前
已完结
Natural killer cells in inflammation and autoimmunity
5个月前
已完结
A γδ T cell–IL-3 axis controls allergic responses through sensory neurons
7个月前
已完结
皖公网安备34019202002308
